Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Influenza Vaccine in Nursing Homes
NCT01815268Phase 4Unknown
- Sponsor
- Insight Therapeutics
- Start
- Feb 2013
- Primary completion
- May 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of influenza virus vaccine, split virion in influenza (4 arms), sponsored by Insight Therapeutics. Primary endpoint: All-cause hospitalization rate at 1 year. Status: unknown.
02
Drugs
influenza virus vaccine, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01815268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01815268.